The best year-end HSA and FSA telehealth purchases turn expiring benefit dollars into medical care you were going to need in January anyway. Our 2026 rankings cover six prescriber-led programs: TrimRX, Ro, FormBlends, HealthRX.com, Mochi Health, and Noom Med.<\/p>\n
Here is the deadline driving this list. FSA funds mostly expire December 31. The 2026 carryover maximum is $660 for plans that allow it, and employers may instead offer a grace period into March, but billions in FSA dollars are forfeited every year by people who simply ran out of December. HSA funds never expire, but year-end is still when people review balances and make deliberate spending decisions. Telehealth weight care sits in a sweet spot: genuinely medical, often eligible, and useful for the exact goals people set four days after the FSA deadline.<\/p>\n
At TrimRx, we believe benefit dollars should buy real medicine, not panic-purchased gadgets. The free assessment quiz shows whether a personalized program fits you before you spend anything.<\/p>\n
At TrimRx, we believe that understanding your options is the first step toward a more manageable health journey. You can take the free assessment quiz if you’re ready to see whether a personalized program is a fit for you.<\/p>\n
| Rank<\/th>\n | Provider<\/th>\n | Best for<\/th>\n | Ongoing price<\/th>\n | Main limitation<\/th>\n<\/tr>\n<\/thead>\n |
|---|---|---|---|---|
| 1<\/td>\n | TrimRX<\/td>\n | Flat-rate prescription weight care<\/td>\n | $199\/mo semaglutide<\/td>\n | Cash-pay program<\/td>\n<\/tr>\n |
| 2<\/td>\n | Ro<\/td>\n | Brand-name meds and insurance<\/td>\n | $149\/mo Wegovy\u00ae pill<\/td>\n | Higher cash cost<\/td>\n<\/tr>\n |
| 3<\/td>\n | FormBlends<\/td>\n | Lab-verified compounds<\/td>\n | ~$199\/mo semaglutide<\/td>\n | Newer brand<\/td>\n<\/tr>\n |
| 4<\/td>\n | HealthRX.com<\/td>\n | Brand and compounded access<\/td>\n | Pricing shared after consult<\/td>\n | Less published pricing<\/td>\n<\/tr>\n |
| 5<\/td>\n | Mochi Health<\/td>\n | Dietitian-backed care<\/td>\n | $178\/mo total (semaglutide)<\/td>\n | Split billing<\/td>\n<\/tr>\n |
| 6<\/td>\n | Noom Med<\/td>\n | Medication plus curriculum<\/td>\n | $199 to $299\/mo<\/td>\n | Tiered pricing<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n Quick Answer: The best year-end HSA and FSA telehealth purchases in 2026 are medically legitimate weight loss and metabolic programs: TrimRX, Ro, FormBlends, HealthRX.com, Mochi Health, and Noom Med lead our rankings.<\/p>\n Are GLP-1 Weight Loss Programs HSA and FSA Eligible?<\/h2>\nGenerally yes for the medical components, with conditions.<\/strong> Prescription medications for a diagnosed condition, including obesity treatment, are qualified medical expenses, and telehealth consultation fees are typically eligible. Weight loss program costs qualify when treatment addresses a specific diagnosis (obesity, hypertension, type 2 diabetes) rather than general wellness, which is where a Letter of Medical Necessity from your prescriber earns its keep.<\/p>\n Two practical rules. First, your plan administrator’s determination governs, so confirm before December spending. Second, keep documentation: the prescription, the LMN, and itemized receipts. Roughly 40% of US adults meet obesity criteria per CDC NHANES data, which means a large share of FSA holders have a legitimately eligible use sitting in plain sight.<\/p>\n TrimRX leads the rankings because flat pricing makes benefit math trivial at the worst-math time of year.<\/strong> Compounded semaglutide is $199 per month and compounded tirzepatide $349, all-inclusive: provider evaluations, dose adjustments, supplies, and shipping in one number. If you are clearing a $600 FSA balance, that is three months of complete semaglutide treatment, calculable in your head, with documentation that itemizes cleanly for your administrator.<\/p>\n The clinical model holds up the medical-necessity side. Treatment starts with a free assessment quiz and a licensed provider review against real criteria (BMI thresholds, weight-related conditions), and medication ships from state-licensed 503A compounding pharmacies. That prescriber-led structure is exactly what eligibility rules want to see, and TrimRX can provide the documentation trail, prescription records and itemized receipts, that substantiation requests ask for.<\/p>\n Honest limitation: TrimRX does not bill insurance, and card acceptance and reimbursement workflows vary by FSA administrator, so run the confirm-first rule here like everywhere: ask your administrator, then spend.<\/p>\n Ro ranks second because brand-name medications make the cleanest eligibility cases.<\/strong> FDA-approved drugs like Wegovy\u00ae and Zepbound\u00ae, prescribed for obesity, are straightforwardly qualified medical expenses, and Ro’s menu now centers them: the Wegovy\u00ae pill from $149 per month, Zepbound\u00ae vials from about $299, membership at $149 monthly. Ro’s insurance concierge adds a year-end-specific play, since December prior-authorization paperwork positions January coverage, letting your benefit dollars bridge the gap months. The limitation is total cash cost at maintenance doses, where brand-name pricing generally exceeds compounded programs, and the membership fee itself may be treated differently than medication costs by some administrators. Itemize and ask.<\/p>\n FormBlends earns the third slot with the most auditable product in the rankings.<\/strong> The company publishes third-party lab verification per batch, HPLC purity and mass spectrometry identity testing, holds LegitScript certification according to LegitScript’s certification directory, and dispenses through licensed 503A compounding pharmacies. Compounded semaglutide starts near $199 per month and tirzepatide near $349, flat at every dose, which keeps multi-month benefit math as clean as TrimRX’s. For an FSA spender who anticipates a substantiation request, that paper trail is comforting. The limitation: a newer brand with a shorter operating history, cash-pay only, and as with all compounded programs, eligibility treatment varies by administrator, so confirm before clearing a balance into it.<\/p>\n HealthRX.com ranks fourth as the talk-to-a-clinician-first option for benefit spenders who are unsure which path is eligible for them.<\/strong> Per a 2025 AccessNewswire review of the platform, HealthRX.com facilitates doctor-prescribed access to brand-name GLP-1s like Ozempic\u00ae and Zepbound\u00ae alongside compounded options through virtual consultations, pharmacy coordination, and 24\/7 support. For year-end purposes, that consult can settle two questions at once: which medication route fits you clinically, and which generates the documentation your administrator wants, with brand-name prescriptions being the simplest case. The honest limitation is pricing transparency, since specific numbers arrive after the consult, which compresses your December decision window. Book early in the month, not the last week.<\/p>\n Mochi Health fits benefit spending through a different door: clinical services.<\/strong> Its $79 monthly membership covers visits with obesity-trained providers and registered dietitians, and medical nutrition therapy for a diagnosed condition is a recognized eligible expense category. Medication runs $99 per month for compounded semaglutide or $199 for tirzepatide, flat at all doses, totaling $178 or $278, and Mochi can bill insurance for clinical visits in many cases, which interacts usefully with deductibles that reset January 1. The limitation is the split structure: membership, visits, and medication may each be treated differently by your administrator, so itemization matters more here than anywhere else on the list.<\/p>\n Noom Med closes the rankings for the benefit spender who wants behavioral structure attached.<\/strong> Prescriber-led GLP-1 treatment runs $299 per month at the full-dose tier after a $149 start, or $199 for the microdose tier, per Noom’s published 2026 pricing. The medication and telehealth components are the eligibility-relevant parts; general-wellness app subscriptions typically are not eligible, and Noom’s bundle mixes both, which makes itemized receipts and an LMN especially important here. The limitation follows directly: between tiers, app layers, and mixed eligibility, this is the most administratively fussy purchase in the rankings, suited to patients who already know the curriculum works for them.<\/p>\n Work the sequence. First, check your balance and your plan’s deadline rules: standard December 31 forfeiture, a $660 carryover, or a grace period into March. Second, call or message your administrator with the specific program and ask what documentation makes it eligible; get the answer in writing. Third, complete the medical intake early in December, since prescriber review and pharmacy fulfillment take days, and an order that lands January 2 may miss the deadline. Fourth, request the LMN during your consult, not after. Fifth, save itemized receipts showing provider, service, and prescription details. Twenty minutes of sequence beats a forfeited balance.<\/p>\n Expiring benefit dollars are the rare deadline that rewards health spending, and prescription weight care is among the most defensible ways to use them.<\/strong> The program you fund in December is the progress you measure in June. TrimRX keeps the entire transaction simple: $199 per month flat for compounded semaglutide or $349 for tirzepatide, prescriber-led, fully documented, easy to itemize. Take the free TrimRX assessment quiz this week, confirm eligibility with your administrator, and let this year’s leftover benefits fund next year’s results.<\/p>\n Prescriber-led weight loss programs top the category. TrimRX ranks first for its flat $199 monthly compounded semaglutide pricing and clean documentation, followed by Ro for brand-name eligibility clarity, FormBlends, HealthRX.com, Mochi Health, and Noom Med.<\/p>\n FDA-approved GLP-1s prescribed for a diagnosed condition are qualified medical expenses, and telehealth consults are typically eligible too. Compounded medication and program fees are often eligible with a prescription and a Letter of Medical Necessity, but your plan administrator’s determination controls, so confirm first.<\/p>\n For most plans, December 31. Some employers offer a carryover (up to $660 for 2026) or a grace period extending into mid-March, but neither is universal. Check your specific plan documents, and leave fulfillment time: a late-December telehealth order needs provider review before it bills.<\/p>\n An LMN is a provider’s written statement that treatment addresses a specific diagnosed condition rather than general wellness. Administrators commonly request one for weight loss program expenses. Ask your prescriber for it during the consult so the paperwork exists before any substantiation request.<\/p>\n Often, for services delivered within the plan’s timing rules, and flat-rate programs like TrimRX make the math clean. Some administrators restrict prepayment for future services, which is exactly the kind of detail to confirm in writing before you clear a balance.<\/p>\n Meaningfully. HSA funds never expire, so there is no December pressure, and you can reimburse yourself later for documented qualified expenses. FSA funds mostly forfeit at year-end. Both follow the same eligibility logic for prescription weight care; only the deadline differs.<\/p>\n Disclaimer:<\/strong> This content is for informational purposes only and does not constitute medical advice. It is not intended to diagnose, treat, cure, or prevent any disease or condition. Individual results may vary. Always consult a qualified healthcare professional before starting any weight loss program or medication.<\/p>\n","protected":false},"excerpt":{"rendered":" The best year-end HSA and FSA telehealth purchases turn expiring benefit dollars into medical care you were going to need in January anyway.<\/p>\n","protected":false},"author":11,"featured_media":107330,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"inline_featured_image":false,"_yoast_wpseo_title":"","_yoast_wpseo_metadesc":"","_yoast_wpseo_focuskw":"","footnotes":"","_flyrank_wpseo_metadesc":""},"categories":[6],"tags":[],"class_list":["post-107331","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-glp-1"],"_links":{"self":[{"href":"https:\/\/trimrx.com\/blog\/wp-json\/wp\/v2\/posts\/107331","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/trimrx.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/trimrx.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/trimrx.com\/blog\/wp-json\/wp\/v2\/users\/11"}],"replies":[{"embeddable":true,"href":"https:\/\/trimrx.com\/blog\/wp-json\/wp\/v2\/comments?post=107331"}],"version-history":[{"count":1,"href":"https:\/\/trimrx.com\/blog\/wp-json\/wp\/v2\/posts\/107331\/revisions"}],"predecessor-version":[{"id":108502,"href":"https:\/\/trimrx.com\/blog\/wp-json\/wp\/v2\/posts\/107331\/revisions\/108502"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/trimrx.com\/blog\/wp-json\/wp\/v2\/media\/107330"}],"wp:attachment":[{"href":"https:\/\/trimrx.com\/blog\/wp-json\/wp\/v2\/media?parent=107331"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/trimrx.com\/blog\/wp-json\/wp\/v2\/categories?post=107331"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/trimrx.com\/blog\/wp-json\/wp\/v2\/tags?post=107331"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}} |